Allogeneic MSC

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Lomecel-B Effects on Alzheimer's DiseaseNCT05233774LGVNPhase 2Completed2023-09-29Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.